ProKidney Corp.
Juliane Bush is a skilled professional with extensive experience in materials management and supply chain operations. Currently serving as the Quality Materials Management Manager at ProKidney Corp. since October 2023, Juliane previously held the position of Materials Management Planning Manager at Thermo Fisher Scientific from March 2020 to October 2023, as well as a Supply Chain Specialist role at the same company. Prior experience includes Commodity Lead - Machining at Cobham Mission Systems (June 2015 - March 2020) and Supply Chain Specialist - Military Global Support at Moog (April 2012 - June 2015), where responsibilities involved purchasing, supplier negotiation, and collaboration on military projects. Earlier career highlights include serving as Purchasing/Project Manager at Visteon Corporation (October 2005 - May 2008). Juliane holds a Bachelor's degree in Business Management from D'Youville University and an Associate's degree in Accounting from Bryant & Stratton, along with a Six Sigma Green Belt certification.
This person is not in the org chart
ProKidney Corp.
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive meaningful improvement in kidney function. Late-stage CKD, Stage 3b - 4, is a key target for REACT™ therapy. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program, which launched in January 2022. For more information, visit www.prokidney.com.